Developing Biosimilars in Emerging Markets: Regulatory and Clinical Considerations 2014
08 Jul 2014
Webinar
Key Topics
General requirements to register a biosimilar product
Introduction - biosimilars
Requirements for comparability data
Regulatory considerations in emerging markets
Overview of key emerging markets
Who should Attend
Senior management executives (CEO, COO, CFO, etc)
Regulatory affairs professionals
Intellectual property experts
Drug discovery and development professionals (R&D and CMC)
Regulatory Compliance Associates and Managers
Project Managers and Clinical trial specialists
People investing in FDA-regulated product development projects
Past Events
Developing Biosimilars in Emerging Markets: Regulatory and Clinical Considerations 2014 - 08 Jul 2014, Webinar (45848)
Developing Biosimilars in Emerging Markets: Regulatory and Clinical Considerations 2026
Important
Please, check "Developing Biosimilars in Emerging Markets: Regulatory and Clinical Considerations" official website for possible changes, before making any traveling arrangements
